The use of Artificial Intelligence (AI) in mental health care is growing fast. In 2024, this market was worth about $1.45 billion, and it’s expected to grow to $11.84 billion by 2034, expanding at a 24.15% growth rate every year.
Get All the Details in Our Solutions – Request a Brochure: https://www.towardshealthcare.com/download-brochure/5568
North America is leading the market right now.
Asia Pacific is catching up quickly and will grow the fastest.
Software-based solutions are the most popular and growing fast.
Natural Language Processing (NLP) tech (used in chatbots, etc.) is leading today.
Machine Learning (ML) is the fastest-growing technology.
Anxiety is the most commonly addressed mental health condition using AI.
Schizophrenia support using AI tools is seeing strong future growth.
1. Mental Health Challenges Are Increasing:
More people are experiencing mental health issues like stress, anxiety, and depression. But there aren’t enough doctors and therapists available. That’s where AI comes in—to help fill the gap.
2. AI Offers Early Detection and Support:
AI tools can help spot signs of mental illness early through apps, chatbots, and predictive models, making it easier to get help sooner.
3. Mental Health Services Are Becoming More Accessible:
With AI, people can access support from their phones anytime, anywhere, making mental health help more available to everyone.
April 2025: Headspace (mindfulness app) and Ginger (therapy platform) merged, forming a $3 billion company focused on digital mental health.
March 2025: Zoom and Lucid Software are improving mental health support in hybrid workplaces using AI tools like Unmind.
Growing mental health concerns
Lack of enough therapists
Increased use of mental health apps
Government efforts to spread awareness
Lack of human interaction: AI can’t offer the same empathy and emotional connection as a real therapist.
Miscommunication risk: AI may not always understand a patient’s background or emotions correctly.
AI is making therapy more personal and accessible
Tools like chatbots are helping people manage their mental health on their own
Software Solutions: Leading the market. Easy to use, available as apps.
Natural Language Processing (NLP): Popular for chatbots that help people express their feelings.
Machine Learning (ML): Growing fast because it helps provide personalized treatment.
Anxiety Treatment: Most common use of AI in mental health today.
Schizophrenia Support: Seeing more AI tools for diagnosis, monitoring, and treatment.
North America: Leading due to advanced healthcare systems and strong support for AI.
USA: Known for using advanced AI tools in therapy.
Canada: Companies are actively building AI solutions for mental health.
Asia Pacific: Fastest-growing region.
China: Launching new apps to support mental health, with government backing.
India: Growing awareness and new AI innovations for mental wellness.
Europe: Strong growth due to rising awareness and government regulations.
Germany: Focused on safe and personalized AI therapies.
UK: Companies are creating new AI-based tools and apps for mental health.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Some of the major players leading the AI in mental health space:
Spring Care
Wysa
Lyra Health
Woebot Health
Microsoft
Headspace Health
Fortis Healthcare
And many more…
Dartmouth College launched Therabot, an AI-based therapy tool, which showed success in helping patients with anxiety and depression.
Dubai Health Authority introduced strict privacy and quality standards for digital therapy tools to ensure safe online mental health care.
To invest in our premium strategic solution and customized market report options, click here: https://www.towardshealthcare.com/price/5568
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More